Anaemia in Ovarian Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anaemia in Ovarian Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 1/2

NCT04954599

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

A modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokinetics of intravenous…

Belgium, Netherlands, Spain126 participantsStarted 2023-05-30

Treatment: CP-506, Carboplatin

RecruitingNot Applicable

NCT06785077

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

Therapy related acute myeloid leukemia and myelodysplasia (t-MN) is a potential late complication of cytotoxic therapy, and it is of particular concern in the t…

Italy157 participantsStarted 2020-10-02

Treatment: buccal cells, bone marrow cells

All recent trials (29 shown)

CompletedPhase 2

NCT00753545

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

The primary purpose of this study to determine if AZD2281 is effective and well tolerated in maintaining the improvement in your cancer after previous platinum-…

United States265 participantsStarted 2008-08-28

Treatment: AZD2281, matching placebo

TerminatedPhase 2

NCT03891576

Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)

This study evaluates whether the adoption of the RADAR dosing strategy could further reduce treatment related toxicities improving the safety profile of nirapar…

Germany, Italy83 participantsStarted 2019-11-13

Treatment: Niraparib

Anaemia in Ovarian Carcinoma

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

All recent trials (29 shown)

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

All recent trials (29 shown)

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated B…

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovaria…

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Methods in Education for Breast Cancer Genetics

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy

Genetic Counseling in African American Women